MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 280 filers reported holding MYRIAD GENETICS INC in Q3 2014. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $201,000 | -74.7% | 10,545 | -61.4% | 0.04% | -81.5% |
| Q4 2018 | $794,000 | -18.7% | 27,297 | +28.6% | 0.19% | -1.6% |
| Q3 2018 | $977,000 | +23.2% | 21,230 | 0.0% | 0.19% | +18.5% |
| Q2 2018 | $793,000 | +71.6% | 21,230 | +35.8% | 0.16% | +65.3% |
| Q1 2018 | $462,000 | -58.6% | 15,630 | -45.5% | 0.10% | -19.7% |
| Q2 2014 | $1,117,000 | – | 28,700 | +286900.0% | 0.12% | – |
| Q4 2013 | $0 | -100.0% | 10 | -100.0% | 0.00% | -100.0% |
| Q3 2013 | $4,069,000 | -14.4% | 173,173 | -2.1% | 0.52% | -19.9% |
| Q2 2013 | $4,754,000 | – | 176,938 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |